ANALYST COVERAGE

Research Capital

Greg McLeish, CFA

“We are initiating coverage of Cannara Biotech Inc. with a BUY rating and a target price of $3.00″

VIEW ANALYSIS

Cannara Biotech Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cannara Biotech Inc.’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cannara Biotech Inc. or its management. Cannara Biotech Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Cannara Biotech Inc.

We stop at nothing to create products that start with one key ingredient, purposefully cultivated premium cannabis flower.

Facebook-f Instagram X-twitter Linkedin Discord
© 2025 Cannara Biotech Inc. All Rights Reserved.
Privacy Policy.

Social Media Policy

Website Design & Development by CryoDragon Inc.